Učitavanje...
Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011
PURPOSE: Distant relapse metastatic breast cancer (rMBC) incidence and survival are vital measures of breast cancer diagnosis and treatment progress over time. METHODS: We conducted a retrospective cohort study of stage I–III invasive breast cancer, 1990–2011, follow-up through 2016 [N = 8292, rMBC ...
Spremljeno u:
| Izdano u: | Breast Cancer Res Treat |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6422972/ https://ncbi.nlm.nih.gov/pubmed/30560462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-05090-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|